after the FDA removed the EUA for two mAbs that don't work. The plan is to save them in case they can be used in the future. It would be the height of irresponsibility to waste them when they would be ineffective for two reasons:
1. Wasting a potentially helpful agent that's difficult to make and already in short supply when we might need it later
2. Someone who is really sick is going to get an ineffective treatment instead of being allocated the one that works or one of the newer oral agents. The patient wastes time and money (which could threaten their life) and nothing good is accomplished
https://apnews.com/article/coronavirus-pandemic-science-business-health-f8cbfdb48f6c78aea16930b45af4e024
I'm a fan of the Jewish leprechaun, but that article is misleading.